icrf 198 has been researched along with dexrazoxane in 2 studies
Studies (icrf 198) | Trials (icrf 198) | Recent Studies (post-2010) (icrf 198) | Studies (dexrazoxane) | Trials (dexrazoxane) | Recent Studies (post-2010) (dexrazoxane) |
---|---|---|---|---|---|
24 | 0 | 4 | 131 | 6 | 121 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Foret, F; Kovarikova, P; Tycova, A; Vido, M | 1 |
Brázdová, P; Bureš, J; Chládek, J; Jirkovská, A; Jirkovský, E; Karabanovich, G; Kovaříková, P; Lenčová, O; Pokorná, Z; Roh, J; Šimůnek, T; Stariat, J; Štěrba, M | 1 |
2 other study(ies) available for icrf 198 and dexrazoxane
Article | Year |
---|---|
Interface-free capillary electrophoresis-mass spectrometry system with nanospray ionization-Analysis of dexrazoxane in blood plasma.
Topics: Blood Chemical Analysis; Dexrazoxane; Electrophoresis, Capillary; Ethylenediamines; Glycine; Spectrometry, Mass, Electrospray Ionization | 2016 |
Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart.
Topics: Animals; Cardiotonic Agents; Dexrazoxane; Ethylenediamines; Glycine; Myocytes, Cardiac; Rabbits; Rats; Tissue Distribution | 2018 |